Creatinine
In clinical developmentAlso known as creatinina.
Recent clinical, regulatory, research and industry developments relating to this drug.
Cardiac Surgery-Associated Acute Kidney Injury.
Cystatin C-Based eGFR Changes during Gender-Affirming Hormone Therapy in Transgender Individuals.
New Creatinine- and Cystatin C-Based Equations to Estimate GFR without Race.
Liraglutide and Renal Outcomes in Type 2 Diabetes.
Clinical Trial of Creatine in Amyotrophic Lateral Sclerosis
Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction.
Profile
Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.
Clinical trials
The current development programme across all trial phases — status mix, phase distribution and the late-stage studies shaping the evidence base.
Recent completions
Trials that read out recently, adding to the completed evidence base.
Research activity
Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.
Major research themes8
Journals, researchers & institutions
- The New England journal of medicine3
- BMC medical informatics and decision making1
- Clinical journal of the American Society of Nephrology : CJASN1
- European heart journal1
- Frontiers in endocrinology1
- Kidney3601
- Adamo M1
- Anavekar NS1
- Arteaga-Muller GY1
- Ballew SH1
- Bezzi M1
- Bjornstad P1
- Bliem HR1
- Bocanegra-Ibarias P1
- A.S.L.) and the Institute for Clinical Research and Health Policy Studies (H.T.)1
- Amsterdam University Medical Centers1
- Biocenter1
- Brigham and Women's Hospital1
- Center of Expertise on Gender Dysphoria1
- Clinic of Nephrology1
Related diseases
Regulator-approved indications and conditions co-mentioned with this drug across the research literature. Number shows shared papers.
Related drugs
Drugs sharing diseases, protein targets and literature with this one. Ranked by graph evidence (shared targets + diseases weighted above co-mentions).
Studied across 8 of the same disease areas as Creatinine in the shared literature.
Studied across 6 of the same disease areas as Creatinine in the shared literature.
Studied across 5 of the same disease areas as Creatinine in the shared literature.
Studied across 5 of the same disease areas as Creatinine in the shared literature.
Studied across 2 of the same disease areas as Creatinine in the shared literature.
Studied across the same disease area as Creatinine in the shared literature.
- RxNorm (U.S. National Library of Medicine) — drug identity
- ChEMBL (EMBL-EBI) & UniProt — pharmacology and targets
- Europe PMC — research literature
- ClinicalTrials.gov — clinical trials